Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Loss
Balance beginning (in shares) at Dec. 31, 2022		143,034,225
Balance beginning at Dec. 31, 2022	$ 376,905	$ 14	$ 371,072	$ 21,772	$ (15,953)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of stock options (in shares)		163,096
Common stock issued upon exercise of stock options	23		23
Vested common stock awards (in shares)		70,670
Stock-based compensation	2,915		2,915
Net income (loss)	9,769			9,769
Other comprehensive income (loss)	1,530				1,530
Ending balance (in shares) at Mar. 31, 2023		143,267,991
Ending balance at Mar. 31, 2023	391,142	$ 14	374,010	31,541	(14,423)
Balance beginning (in shares) at Dec. 31, 2023		145,706,531
Balance beginning at Dec. 31, 2023	422,507	$ 15	382,854	45,570	(5,932)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of stock options (in shares)		585,760
Common stock issued upon exercise of stock options	83		83
Vested common stock awards (in shares)		212,633
Stock-based compensation	2,781		2,781
Net income (loss)	(13,913)			(13,913)
Other comprehensive income (loss)	(3,274)				(3,274)
Ending balance (in shares) at Mar. 31, 2024		146,504,924
Ending balance at Mar. 31, 2024	$ 408,184	$ 15	$ 385,718	$ 31,657	$ (9,206)